2 ms·
That’s list price. Interestingly, net prices have barely budged in the last decade. Up only single digit percentage.[1] As the list price rose and rebates gre
by refurb 8y ago
That’s list price. Interestingly, net prices have barely budged in the last decade. Up only single digit percentage.[1]
As the list price rose and rebates grew, Novo ended up paying more and more rebate money into the health insurance system. Employers used these extra payments to offset costs in any area, including hospital and physician payments. Health plans used them to reduce premiums and also offset other healthcare costs. PBMs retained a portion of these rebates as their profits.
[1]https://www.drugchannels.net/2016/12/novo-nordisk-sheds-new-light-on-pbm.html?m=1 https://www.drugchannels.net/2016/12/novo-nordisk-sheds-new-...
- ceejayoz 8y agohttps://www.nytimes.com/2018/07/27/health/rebates-high-drug-prices-trump.html https://www.nytimes.com/2018/07/27/health/rebates-high-drug-... > Even as insurers’ drug spending has grown slowly, critics say the rebate game has served to inflate the list price of drugs, which consumers are increasingly responsible for paying. This is especially true for expensive specialty drugs, which treat serious conditions like cancer and multiple sclerosis — and whose prices have been skyrocketing. > As the cost of these products has gone up, insurers have raised deductibles and out-of-pocket contributions so that many of the sickest Americans must now pay thousands of dollars a year to cover their drug costs. These out-of-pocket costs are calculated using something close to the list price of a product, not the net price.
- refurb 8y agoThat is very true. If your insurance requires a copay, it’s on the list price, not net. Sometimes the discount is so big that 20% of the list price is more than the entire net price of the drug.